List of publications not discussed in this thesis van den Hof S, van der Kooi T, van den Berg R, Kuijper EJ, Notermans DW. Clostridium difficile PCR ribotype 027 outbreaks in the Netherlands: recent surveillance data indicate that outbreaks are not easily controlled but interhospital transmission is limited. Euro Surveill. 2006;11(1):E060126 2 https://doi.org/10.2807/esw.11.04.02882‐en. Goorhuis A, Van der Kooi T, Vaessen N, Dekker FW, Van den Berg R, Harmanus C, et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis. 2007;45(6):695‐703 https://doi.org/10.1086/520984. Notermans DW, van der Kooi TI, Goorhuis A, Debast SB, van Benthem BH, Kuijper EJ. [Epidemiology of Clostridium difficile PCR ribotype 027 in the Netherlands 2005‐present and the emergence of other subtypes]. Ned Tijdschr Geneeskd. 2008;152(35):1937‐40. van der Kooi TII, Koningstein M, Lindemans A, Notermans DW, Kuijper E, van den Berg R, et al. Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027. J Med Microbiol. 2008;57(Pt 6):709‐16 https://doi.org/10.1099/jmm.0.47711‐0. Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tull P, Gastmeier P, et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect. 2008;14 Suppl 5:2‐20 https://doi.org/10.1111/j.1469‐0691.2008.01992.x. Willemsen I, van der Kooi T, van Benthem B, Wille J, Kluytmans J. Appropriateness of antimicrobial therapy: a multicentre prevalence survey in the Netherlands, 2008‐2009. Euro Surveill. 2010;15(46) https://doi.org/10.2807/ese.15.46.19715‐en. Jansen IA, Hopmans TE, Wille JC, van den Broek PJ, van der Kooi TI, van Benthem BH. Appropriate use of indwelling urethra catheters in hospitalized patients: results of a multicentre prevalence study. BMC Urol. 2012;12:25 https://doi.org/10.1186/1471‐2490‐ 12‐25. Clack L, Zingg W, Saint S, Casillas A, Touveneau S, da Liberdade Jantarada F, et al. Implementing infection prevention practices across European hospitals: an in‐depth qualitative assessment. BMJ Qual Saf. 2018;27(10):771‐80 https://doi.org/10.1136/bmjqs‐2017‐ 007675. Koek MBG, van der Kooi TII, Stigter FCA, de Boer PT, de Gier B, Hopmans TEM, et al. Burden of surgical site infections in the Netherlands: cost analyses and disability‐adjusted life years. J Hosp Infect. 2019;103(3):293‐302 https://doi.org/10.1016/j.jhin.2019.07.010. Hopmans TEM, Smid EA, Wille JC, van der Kooi TII, Koek MBG, Vos MC, et al. Trends in prevalence of healthcare‐associated infections and antimicrobial use in hospitals in the Netherlands: 10 years of national point‐prevalence surveys. J Hosp Infect. 2020;104(2):181‐7 https://doi.org/10.1016/j.jhin.2019.10.005. Verberk JD, van der Kooi TI, Derde LP, Bonten MJ, de Greeff SC, van Mourik MS. Do we need to change catheter‐related bloodstream infection surveillance in the Netherlands? A qualitative study among infection prevention professionals. BMJ Open. 2021;11(8):e046366 https://doi.org/10.1136/bmjopen‐2020‐046366. Verberk JDM, van der Kooi TII, Hetem DJ, Oostdam N, Noordergraaf M, de Greeff SC, et al. Semiautomated surveillance of deep surgical site infections after colorectal surgeries: A multicenter external validation of two surveillance algorithms ‐ ERRATUM. Infect Control Hosp Epidemiol. 2023;44(7):1208 https://doi.org/10.1017/ice.2022.213. 284 List of publications
RkJQdWJsaXNoZXIy MTk4NDMw